Jenscare Scientific Co. Ltd. Class H (HK:9877) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jenscare Scientific Co., Ltd. has announced promising results from its TRAVEL II study, showcasing the LuX-Valve Plus system’s impressive efficacy and safety in treating severe tricuspid regurgitation. With a high device success rate of 97% and significant improvements in patients’ quality of life, these findings highlight the potential of Jenscare’s innovative medical solutions.
For further insights into HK:9877 stock, check out TipRanks’ Stock Analysis page.